Guardant Health, Inc.
corporate_fare Company Profile
Guardant Health, Inc. (NASDAQ:GH) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 24 items for GH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for GH spans 8-K, 10-Q, DEF 14A.
Recent high-impact activity:
- Guardant Closes Upsized $550M 0% Convertible Notes Due 2032, Refinances 2027 Notes
- $500M 0% Convertible Notes Priced at 35% Premium; Proceeds to Retire 2027 Notes
- $500M Convertible Notes Offering Announced, With 2027 Note Repurchase
- Guardant Q3 Revenue Jumps 36% to $361M; Convertible Notes Turn Convertible
- Q3 Revenue Jumps 36% to $361M, 2026 Guidance Raised on Shield Momentum
Financial Snapshot
Short Interest & Short Volume
5.38 days to coverFINRA reported short interest of 9,433,137 shares in GH as of the October 30, 2026 settlement, a 19.2% decrease from the prior period — about 5.4 days to cover at its recent average daily volume. On November 20, 2026, 41.1% of GH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for GH, detected from its recent SEC filings · based on capital-structure filings through 2026-11-16.
Upsized $550M Convertible Notes Close · Proceeds Refinance 2027 Notes
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →